ARGX (ARGX) Stock Price & Analysis
ARGX (ARGX) fell 1.93% to USD 1,033.15 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
ARGX last closed at USD 1,033.15; the session ranged USD 1,031.19–1,048.44 on volume of 125,058 shares. Market capitalization is —, with a 52-week range of USD 661.85–1,072.75 (NMS). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 1,033.15 |
|---|---|
| Change | ▼ 1.93% (down) |
| Previous Close | USD 1,033.15 |
| Open | USD 1,033.15 |
| Day Range | USD 1,031.19 – 1,048.44 |
| 52-Week Range | USD 661.85 – 1,072.75 |
| Volume | 125,058 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ARGX)
Nexqual's technical model rates ARGX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.63 (neutral) |
| vs SMA50 | Above (USD 925.41) |
| MACD | 41.11 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ASND | Ascendis Pharma A/S | USD 270.56 | ▲ 1.22% |
| KRYS | Krystal Biotech, Inc. | USD 358.24 | ▼ 2.98% |
| GMAB | Genmab A/S | USD 33.6 | ▼ 1.8% |
| ALNY | Alnylam Pharmaceuticals, Inc. | USD 266.11 | ▼ 0.48% |
| MDGL | Madrigal Pharmaceuticals, Inc. | USD 541.08 | ▼ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.